Your browser doesn't support javascript.
loading
Emerging Therapeutics, Technologies, and Drug Development Strategies to Address Patient Nonadherence and Improve Tuberculosis Treatment.
Garcia-Cremades, Maria; Solans, Belen P; Strydom, Natasha; Vrijens, Bernard; Pillai, Goonaseelan Colin; Shaffer, Craig; Thomas, Bruce; Savic, Rada M.
Afiliação
  • Garcia-Cremades M; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, California 94158, USA; email: rada.savic@ucsf.edu.
  • Solans BP; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, California 94158, USA; email: rada.savic@ucsf.edu.
  • Strydom N; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, California 94158, USA; email: rada.savic@ucsf.edu.
  • Vrijens B; AARDEX Group, B-4102 Liège Science Park, Belgium.
  • Pillai GC; Department of Public Health, University of Liège, B-4000 Liège, Belgium.
  • Shaffer C; Division of Clinical Pharmacology, University of Cape Town, 7925 Observatory, South Africa.
  • Thomas B; CP+ Associates GmbH, 4102 Basel, Switzerland.
  • Savic RM; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, California 94158, USA; email: rada.savic@ucsf.edu.
Annu Rev Pharmacol Toxicol ; 62: 197-210, 2022 01 06.
Article em En | MEDLINE | ID: mdl-34591605
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adesão à Medicação / Desenvolvimento de Medicamentos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Annu Rev Pharmacol Toxicol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adesão à Medicação / Desenvolvimento de Medicamentos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Annu Rev Pharmacol Toxicol Ano de publicação: 2022 Tipo de documento: Article